Search

everythinglearnresearchcommunity

for

Search:↓

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Hypothyroidism in dogs is usually caused by immune system issues or gland atrophy, affects middle-aged purebreds most, and is treatable with medication.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

CD2 might be a new treatment target for patchy alopecia areata.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

People with alopecia have a higher risk of thyroid cancer.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Type I interferons play a key role in the development of various skin diseases.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.